The Role of Surrogate Markers in the Clinical Evaluation of Antituberculous Chemotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-600x|4|4|287-294

ISSN： 1568-0126

Source： Current Medicinal Chemistry - Anti-Infective Agents, Vol.4, Iss.4, 2005-10, pp. : 287-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of drug-metabolising enzymes in clinical responses to chemotherapy

By Scripture Charity D   Figg William D   Sparreboom Alex  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 2, Iss. 1, 2006-02 ,pp. : 17-25

Informa Healthcare

Access to resources Recommend Favorite

Reply to progression-free survival: Does a correlation with survival justify its role as a surrogate clinical endpoint?

By Becker Andreas   Eichelberg Christian   Sun Maxine  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1906-1907

Blackwell Publishing

Access to resources Recommend Favorite

Progression-free survival: Does a correlation with survival justify its role as a surrogate clinical endpoint?

By Halabi Susan   Rini Brian I.   Escudier Bernard   Stadler Walter M.   Small Eric J.  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1906-1906

Blackwell Publishing

Access to resources Recommend Favorite

MDM2 and Human Malignancies: Expression, Clinical Pathology, Prognostic Markers, and Implications for Chemotherapy

By  

Current Cancer Drug Targets, Vol. 5, Iss. 1, 2005-02 ,pp. : 27-41

Bentham Science Publishers

Access to resources Recommend Favorite

New Surrogate Markers for Coronary Heart Disease

By  

Heart Drug, Vol. 1, Iss. 5, 2002-01 ,pp. : 242-243

Karger

Access to resources Recommend Favorite